Skip to main content
[Preprint]. 2024 Jan 10:2023.01.16.23284631. Originally published 2023 Jan 18. [Version 3] doi: 10.1101/2023.01.16.23284631

Table 2.

Associationsa of the plasma omega-6/omega-3 PUFAs ratio with all-cause, cancer, and CVD mortality risk in the UK Biobank.

Causes of death
Omega ratio variable forms All-cause
Cancer
Cardiovascular diseases
Number of deaths Partially adjusted associationsb Fully adjusted associationsc Number of deaths Partially adjusted associationsb Fully adjusted associationsc Number of deaths Partially adjusted associationsb Fully adjusted associationsc
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)

Continuous 6,461 1.02 (1.02–1.03) 1.02 (1.02–1.03) 2,794 1.02 (1.01–1.03) 1.01 (1.00–1.02) 1,668 1.02 (1.01–1.03) 1.02 (1.01–1.03)

Quintiles (median)

1 (5.9) 1,348 1.00 (ref) 1.00 (ref) 593 1.00 (ref) 1.00 (ref) 369 1.00 (ref) 1.00 (ref)
2 (7.6) 1,256 1.00 (0.92–1.08) 0.96 (0.88–1.05) 563 1.02 (0.91–1.15) 0.98 (0.86–1.12) 315 0.90 (0.77–1.05) 0.89 (0.75–1.06)
3 (9.1) 1,236 1.06 (0.98–1.15) 1.01 (0.93–1.11) 543 1.08 (0.96–1.21) 0.99 (0.87–1.13) 321 0.97 (0.84–1.13) 0.97 (0.81–1.16)
4 (11.0) 1,252 1.14 (1.06–1.23) 1.09 (1.00–1.19) 548 1.16 (1.03–1.31) 1.12 (0.98–1.27) 306 0.98 (0.84–1.15) 1.02 (0.86–1.22)
5 (14.8) 1,369 1.34 (1.24–1.45) 1.26 (1.15–1.38) 547 1.27 (1.12–1.43) 1.14 (1.00–1.31) 357 1.20 (1.04–1.40) 1.31 (1.10–1.55)
P trend <0.001 <0.001 <0.001 0.011 0.002 <0.001

Abbreviations: CI, confidence interval; HR, hazards ratio; ref, reference.

a

From Cox proportional hazards regression.

b

Adjusted for age (years; continuous), sex (male, female), race (White, Black, Asian, Others), Townsend deprivation index (continuous), assessment centre.

c

Adjusted for age (years; continuous), sex (male, female), race (White, Black, Asian, Others), Townsend deprivation index (continuous), assessment centre, BMI (kg/m2; continuous), smoking status (never, previous, current), alcohol intake status (never, previous, current), physical activity (low, moderate, high), and comorbidities (yes, no).